Malignant Carcinoid Syndrome - 25 Studies Found
Completed |
: Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors : Carcinoid Tumors : 2004-07-30 : Drug: Pasireotide (SOM230) Open label. Patients received starting dose of 300 µg of study drug subc |
Completed |
: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors :
: 2008-01-25 :
|
Completed |
: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors :
|
Completed |
: Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery :
|
Completed |
: Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors :
|